(Q42267589)
Statements
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma (English)
R V Smalley
A A Bartolucci
G Hemstreet
1 February 1981